Asklepios Klinik Altona

Hamburg, Germany
Medical clinic in Hamburg
Paul-Ehrlich-Straße 1, 22763 Hamburg

About Asklepios Klinik Altona


"Bei Asklepios steht der Mensch im Mittelpunkt. Unsere Mitarbeiterinnen und Mitarbeiter behandeln in unseren Klinken und Lehrkrankenhäusern bundesweit pro Jahr mehr als zwei Millionen Patientinnen und Patienten auf höchstem medizinischen Niveau nach höchsten Qualitätsstandards. Dabei verfolgen wir stets den Anspruch, jeder Patientin und jedem Patienten eine bestmögliche Behandlung in einem jederzeit sicheren Umfeld bei gleichzeitig persönlicher Zuwendung zukommen zulassen. Ob Krankenhaus der Maximalversorgung, spezialisierte Fach- oder Rehaklinik, bei uns werden Sie von hochqualifizierten Fachkräften nach modernsten medizinischen Standards versorgt."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
7
Universitätsklinikum Hamburg-Eppendorf
7
University of Ulm
6
Biotronik SE & Co. KG
4
Boehringer Ingelheim
4
CVRx, Inc.
3
German High-Grade Non-Hodgkin's Lymphoma Study Group
3
Incyte Corporation
3
BioNTech SE
2
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
2
Ipsen
2
Total Rows: 53

Clinical Trials at Asklepios Klinik Altona


During the past decade, Asklepios Klinik Altona conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 12 clinical trials were completed, i.e. on average, 26.7% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 9 clinical trials were completed. i.e. 45% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years445566664499446611000000003322443300Started TrialsCompleted Trails2015201620172018201920202021202220230510
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia
1997-07-01
Unknown status
1,000
Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
2001-01-01
2010-08-05
Completed
1,506
Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
2002-04-01
2006-12-05
Completed
392
Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer
2003-05-01
Completed
86
Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
2004-02-01
2015-11-01
Completed
586
Closed Loop Stimulation, Cognitive Performance, and Quality of Life in Pacemaker Patients
2006-05-01
2011-03-01
Completed
405
Isthmus Ablation With Gold Electrode for Treatment of Atrial Flutter (AURUM 8)
2004-06-01
2008-03-01
Completed
463
Home Monitoring in Cardiac Resynchronisation Therapy
2005-03-01
2008-11-01
Completed
513

Rows per page:

1–87 of 87

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Asklepios Klinik Altona" #1 sponsor was "Janssen Research & Development, LLC" with 7 trials, followed by "Universitätsklinikum Hamburg-Eppendorf" with 7 trials sponsored, "University of Ulm" with 6 trials sponsored, "Biotronik SE & Co. KG" with 4 trials sponsored and "Boehringer Ingelheim" with 4 trials sponsored. Other sponsors include 54 different institutions and companies that sponsored additional 53 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Asklepios Klinik Altona" #1 collaborator was "ClinAssess GmbH" with 2 trials as a collaborator, "ARMO BioSciences" with 1 trials as a collaborator, "Aesculap AG" with 1 trials as a collaborator, "Alfried Krupp Krankenhaus" with 1 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 39 trials.
Created with Highcharts 11.1.0Top Leading SponsorsJanssen Research &Development, LLC: 7Janssen Research &Development, LLC: 7UniversitätsklinikumHamburg-Eppendorf: 7UniversitätsklinikumHamburg-Eppendorf: 7University of Ulm: 6University of Ulm: 6Biotronik SE & Co. KG: 4Biotronik SE & Co. KG: 4Boehringer Ingelheim: 4Boehringer Ingelheim: 4CVRx, Inc.: 3CVRx, Inc.: 3German High-GradeNon-Hodgkin'sLymphoma StudyGroup: 3German High-GradeNon-Hodgkin'sLymphoma StudyGroup: 3Incyte Corporation: 3Incyte Corporation: 3BioNTech SE: 2BioNTech SE: 2Gesellschaft furMedizinische Innovation- Hamatologie undOnkologie mbH: 2Gesellschaft furMedizinische Innovation- Hamatologie undOnkologie mbH: 2

Created with Highcharts 11.1.0Top CollaboratorsClinAssess GmbH: 2ClinAssess GmbH: 2ARMO BioSciences: 1ARMO BioSciences: 1Aesculap AG: 1Aesculap AG: 1Alfried Krupp Krankenhaus: 1Alfried Krupp Krankenhaus: 1Amgen: 1Amgen: 1ArbeitsgemeinschaftmedikamentoeseTumortherapie: 1ArbeitsgemeinschaftmedikamentoeseTumortherapie: 1Asklepios KlinikenGmbH & Co. KGaA: 1Asklepios KlinikenGmbH & Co. KGaA: 1Asklepios KlinikenHamburg GmbH: 1Asklepios KlinikenHamburg GmbH: 1Boehringer Ingelheim: 1Boehringer Ingelheim: 1CHUGAI sanofi-aventis: 1CHUGAI sanofi-aventis: 1

Clinical Trials Conditions at Asklepios Klinik Altona


According to Clinical.Site data, the most researched conditions in "Asklepios Klinik Altona" are "Multiple Myeloma" (7 trials), "Acute Myeloid Leukemia" (4 trials), "Acute Myeloid Leukemia (AML)" (3 trials), "Colorectal Cancer" (3 trials) and "Ischemic Stroke" (3 trials). Many other conditions were trialed in "Asklepios Klinik Altona" in a lesser frequency.

Clinical Trials Intervention Types at Asklepios Klinik Altona


Most popular intervention types in "Asklepios Klinik Altona" are "Drug" (57 trials), "Device" (19 trials), "Biological" (11 trials), "Procedure" (7 trials) and "Other" (6 trials). Other intervention types were less common.
The name of intervention was led by "Dexamethasone" (10 trials), "Placebo" (7 trials), "Carfilzomib" (6 trials), "Cytarabine" (5 trials) and "Lenalidomide" (5 trials). Other intervention names were less common.

Clinical Trials Genders at Asklepios Klinik Altona


The vast majority of trials in "Asklepios Klinik Altona" are 84 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Clinical Trials Status at Asklepios Klinik Altona


Currently, there are NaN active trials in "Asklepios Klinik Altona". undefined are not yet recruiting, 24 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in Asklepios Klinik Altona, undefined suspended trials, and 8 terminated clinical trials to date.
Out of the total trials that were conducted in Asklepios Klinik Altona, 5 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 5 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 36Phase 3: 36Phase 2: 25Phase 2: 25Not Applicable: 5Not Applicable: 5Phase 1: 5Phase 1: 5Phase 4: 5Phase 4: 5

Created with Highcharts 11.1.0Trials StatusCompleted: 40Completed: 40Recruiting: 24Recruiting: 24Active, not recruiting: 8Active, not recruiting: 8Terminated: 8Terminated: 8Unknown status: 6Unknown status: 6Withdrawn: 1Withdrawn: 1